The psychiatric manifestations of mitochondrial disorders: A case and review of the literature

Journal of Clinical Psychiatry

Volumn 73, Issue 4, 2012, Pages 506-512

  Anglin, Rebecca E ^a   Garside, Sarah L ^a   Tarnopolsky, Mark A ^a   Mazurek, Michael F ^a   Rosebush, Patricia I ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CREATINE; CYANOCOBALAMIN; LORAZEPAM; NEUROLEPTIC AGENT; PERPHENAZINE; RIBOFLAVIN; SERTRALINE; THIOCTIC ACID; UBIDECARENONE; VITAMIN D;

ADULT; AMBLYOPIA; AUDITORY HALLUCINATION; AUTOMUTILATION; BORDERLINE STATE; CARPAL TUNNEL SYNDROME; CASE REPORT; CLONUS; CONFUSION; DEMYELINATION; DEPRESSION; DEPRESSIVE PSYCHOSIS; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSARTHRIA; DYSDIADOCHOKINESIA; DYSMETRIA; DYSPHAGIA; DYSTONIA; ELECTROCONVULSIVE THERAPY; FAMILY HISTORY; FATIGUE; FECES INCONTINENCE; FEMALE; GAIT DISORDER; GENE MUTATION; HEARING LOSS; HUMAN; HUMAN TISSUE; HYPERTENSION; MELAS SYNDROME; MENTAL DISEASE; MOOD DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PRIORITY JOURNAL; PTOSIS; RETROLENTAL FIBROPLASIA; REVIEW; SLEEP DISORDER; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR; TREATMENT RESISTANT DEPRESSION; URINE INCONTINENCE; WEAKNESS;

EID: 84860594239     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11r07237     Document Type: Review

References (61)

1. Calvo SE, Mootha VK. The mitochondrial proteome and human disease. Annu Rev Genomics Hum Genet. 2010;11(1):25-44. doi:10.146/anurev-genom-082509-141720 PubMed
2. DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med. 2003;348(26):2656-2668. doi:10.1056/NEJMra02567 PubMed (Pubitemid 36741594)
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
4. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science. 1988;242(4884):1427-1430. doi:10.126/science.3201231 PubMed (Pubitemid 19008070)
5. Chinnery PF, Johnson MA, Wardell TM, et al. The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol. 2000;48(2): 188-193. doi:10.102/1531-8249(208)48:2〈18:AID-ANA8〉3.0.CO;2-PubMed (Pubitemid 30617037)
6. Schaefer AM, McFarland R, Blakely EL, et al. Prevalence of mitochondrial DNA disease in adults. Ann Neurol. 2008;63(1):35-39. doi:10.102/ana.21217 PubMed (Pubitemid 351240549)
7. Clay HB, Sillivan S, Konradi C. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci. 2011;29(3):311-324. doi:10.1016/j.ijdevneu.2010.08.07 PubMed
8. Fattal O, Link J, Quinn K, et al. Psychiatric comorbidity in 36 adults with mitochondrial cytopathies. CNS Spectr. 2007;12(6):429-438. PubMed (Pubitemid 47035289)
9. Ahn MS, Sims KB, Frazier JA. Risperidone-induced psychosis and depression in a child with a mitochondrial disorder. J Child Adolesc Psychopharmacol. 2005;15(3):520-525. doi:10.1089/cap.205.15.520 PubMed (Pubitemid 41192836)
10. Amemiya S, Hamamoto M, Goto Y, et al. Psychosis and progressing dementia: presenting features of a mitochondriopathy. Neurology. 2000;55(4):600-601. PubMed (Pubitemid 30647271)
11. Apostolova LG, White M, Moore SA, et al. Deep white matter pathologic features in watershed regions: a novel pattern of central nervous system involvement in MELAS. Arch Neurol. 2005;62(7):1154-1156. doi:10.101/archneur.62. 7.154 PubMed (Pubitemid 41043741)
12. Ban S, Mori N, Saito K, et al. An autopsy case of mitochondrial encephalomyopathy (MELAS) with special reference to extraneuromuscular abnormalities. Acta Pathol Jpn. 1992;42(11):818-825. PubMed (Pubitemid 23020393)
13. Clark JM, Marks MP, Adalsteinsson E, et al. MELAS: Clinical and pathologic correlations with MRI, xenon/CT, and MR spectroscopy. Neurology. 1996;46(1):223-227. PubMed (Pubitemid 26156134)
14. Campos Y, García A, Eiris J, et al. Mitochondrial myopathy, cardiomyopathy and psychiatric illness in a Spanish family harbouring the mtDNA 3303C > T mutation. J Inherit Metab Dis. 2001;24(6):685-687. doi:10.1023/A:101271921505 PubMed (Pubitemid 33130091)
15. Desnuelle C, Pellissier JF, Serratrice G, et al. [Kearns-Sayre syndrome: mitochondrial encephalomyopathy caused by deficiency of the respiratory chain]. Rev Neurol (Paris). 1989;145(12):842-850. PubMed
16. Gardner A, Pagani M, Wibom R, et al. Alterations of rCBF and mitochondrial dysfunction in major depressive disorder: a case report. Acta Psychiatr Scand. 2003;107(3):233-239. doi:10.1034/j.160-047.203.0218.x PubMed
17. Inagaki T, Ishino H, Seno H, et al. Psychiatric symptoms in a patient with diabetes mellitus associated with point mutation in mitochondrial DNA. Biol Psychiatry. 1997;42(11):1067-1069. doi:10.1016/S06-323(97)0351-X PubMed (Pubitemid 27496437)
18. Jaksch M, Lochmuller H, Schmitt F, et al. A mutation in mt tRNALeu(UUR) causing a neuropsychiatric syndrome with depression and cataract. Neurology. 2001;57(10):1930-1931. PubMed (Pubitemid 33096717)
19. Kaido M, Fujimura H, Soga F, et al. Alzheimer-type pathology in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Acta Neuropathol. 1996;92(3):312-318. doi:10.107/s0401050524 PubMed (Pubitemid 26278964)
20. Kiejna A, DiMauro S, Adamowski T, et al. Psychiatric symptoms in a patient with the clinical features of MELAS. Med Sci Monit. 2002;8(7):CS66-CS72. PubMed (Pubitemid 34826780)
21. Köller H, Kornischka J, Neuen-Jacob E, et al. Persistent organic personality change as rare psychiatric manifestation of MELAS syndrome. J Neurol. 2003;250(12):1501-1502. PubMed doi:10.107/s0415-03-0260-8
22. Lacey CJ, Salzberg MR, Roberts H, et al. Psychiatric comorbidity and impact on health service utilization in a community sample of patients with epilepsy. Epilepsia. 2009;50(8):1991-1994. doi:10.1/j.1528-167.209.02165.x PubMed
23. Miyaoka H, Suzuki Y, Taniyama M, et al. Mental disorders in diabetic patients with mitochondrial transfer RNA(Leu) (UUR) mutation at position 3243. Biol Psychiatry. 1997;42(6):524-526. doi:10.1016/S06-323(97)0280-1 PubMed (Pubitemid 27394622)
24. Mizukami K, Sasaki M, Suzuki T, et al. Central nervous system changes in mitochondrial encephalomyopathy: light and electron microscopic study. Acta Neuropathol. 1992;83(4):449-452. doi:10.107/BF0713541 PubMed
25. Nørby S, Lestienne P, Nelson I, et al. Juvenile Kearns-Sayre syndrome initially misdiagnosed as a psychosomatic disorder. J Med Genet. 1994;31(1):45-50. doi:10.136/jmg.31.1.45 PubMed (Pubitemid 24037946)
26. Odawara M, Isaka M, Tada K, et al. Diabetes mellitus associated with mitochondrial myopathy and schizophrenia: a possible link between diabetes mellitus and schizophrenia. Diabet Med. 1997;14(6):503. doi:10.102/(SICI)1096- 9136(19706)14:6<503:AID-DIA394>3.0.CO;2-1 PubMed
27. Onishi H, Kawanishi C, Iwasawa T, et al. Depressive disorder due to mitochondrial transfer RNALeu(UUR) mutation. Biol Psychiatry. 1997;41(11):1137-1139. doi:10.1016/S06-323(97)05-X PubMed (Pubitemid 27240008)
28. Prayson RA, Wang N. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS) syndrome: an autopsy report. Arch Pathol Lab Med. 1998;122(11):978-981. PubMed (Pubitemid 28521044)
29. Saijo T, Naito E, Ito M, et al. Therapeutic effect of sodium dichloroacetate on visual and auditory hallucinations in a patient with MELAS. Neuropediatrics. 1991;22(3):166-167. doi:10.105/s-208-1071436 PubMed
30. Sartor H, Loose R, Tucha O, et al. MELAS: a neuropsychological and radiological follow-up study. Mitochondrial encephalomyopathy, lactic acidosis and stroke. Acta Neurol Scand. 2002;106(5):309-313. doi:10.1034/j.160-0404.202. 01089.x PubMed
31. Shanske AL, Shanske S, Silvestri G, et al. MELAS point mutation with unusual clinical presentation. Neuromuscul Disord. 1993;3(3):191-193. doi:10.1016/0960-896(93)9058-R PubMed (Pubitemid 23250402)
32. Shinkai T, Nakashima M, Ohmori O, et al. Coenzyme Q10 improves psychiatric symptoms in adult-onset mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: a case report. Aust N Z J Psychiatry. 2000;34(6):1034-1035. doi:10.1080/048670286 PubMed
33. Spellberg B, Carroll RM, Robinson E, et al. mtDNA disease in the primary care setting. Arch Intern Med. 2001;161(20):2497-2500. doi:10.101/archinte.161. 20.2497 PubMed (Pubitemid 33043124)
34. Stewart JB, Naylor GJ. Manic-depressive psychosis in a patient with mitochondrial myopathy - a case report. Med Sci Res. 1990;18:265-266. (Pubitemid 20157040)
35. Suomalainen A, Majander A, Haltia M, et al. Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia. J Clin Invest. 1992;90(1):61-66. doi:10.172/JCI15856 PubMed
36. Suzuki T, Koizumi J, Shiraishi H, et al. Psychiatric disturbance in mitochondrial encephalomyopathy. J Neurol Neurosurg Psychiatry. 1989;52(7):920-922. doi:10.136/jnp.52.7.920-a PubMed
37. Suzuki T, Koizumi J, Shiraishi H, et al. Mitochondrial encephalomyopathy (MELAS) with mental disorder: CT, MRI and SPECT findings. Neuroradiology. 1990;32(1):74-76. doi:10.107/BF0593949 PubMed (Pubitemid 20084615)
38. Sweeney MG, Bundey S, Brockington M, et al. Mitochondrial myopathy associated with sudden death in young adults and a novel mutation in the mitochondrial DNA leucine transfer RNA(UUR) gene. Q J Med. 1993;86(11):709-713. PubMed
39. Thomeer EC, Verhoeven WM, van de Vlasakker CJ, et al. Psychiatric symptoms in MELAS; a case report. J Neurol Neurosurg Psychiatry. 1998;64(5):692-693. doi:10.136/jnp.64.5.692 PubMed (Pubitemid 28204172)
40. Yamazaki M, Igarashi H, Hamamoto M, et al. [A case of mitochondrial encephalomyopathy with schizophrenic psychosis, dementia and neuroleptic malignant syndrome]. Rinsho Shinkeigaku. 1991;31(11):1219-1223. PubMed
41. Grover S, Padhy SK, Das CP, et al. Mania as a first presentation in mitochondrial myopathy. Psychiatry Clin Neurosci. 2006;60(6):774-775. doi:10.1/j.140-1819.206.0159.x PubMed (Pubitemid 44736608)
42. Hopkins SE, Somoza A, Gilbert DL. Rare autosomal dominant POLG1 mutation in a family with metabolic strokes, posterior column spinal degeneration, and multi-endocrine disease. J Child Neurol. 2010;25(6):752-756. doi:10.17/08307380934313 PubMed
43. Koene S, Kozicz TL, Rodenburg RJ, et al. Major depression in adolescent children consecutively diagnosed with mitochondrial disorder. J Affect Disord. 2009;114(1-3):327-332. doi:10.1016/j.jad.208.06.023 PubMed
44. Komulainen T, Hinttala R, Kärppä M, et al. POLG1 p.R722H mutation associated with multiple mtDNA deletions and a neurological phenotype. BMC Neurol. 2010;10(1):29. doi:10.186/1471-237-10-29 PubMed
45. Mancuso M, Ricci G, Choub A, et al. Autosomal dominant psychiatric disorders and mitochondrial DNA multiple deletions: report of a family. J Affect Disord. 2008;106(1-2):173-177. doi:10.1016/j.jad.207.05.016 PubMed (Pubitemid 350309660)
46. Rantamäki M, Krahe R, Paetau A, et al. Adult-onset autosomal recessive ataxia with thalamic lesions in a Finnish family. Neurology. 2001;57(6):1043-1049. PubMed (Pubitemid 32880201)
47. Siciliano G, Tessa A, Petrini S, et al. Autosomal dominant external ophthalmoplegia and bipolar affective disorder associated with a mutation in the ANT1 gene. Neuromuscul Disord. 2003;13(2):162-165. doi:10.1016/S0960-896(02) 021-3 PubMed (Pubitemid 36140012)
48. Verhoeven WM, Egger JI, Kremer BP, et al. Recurrent major depression, ataxia, and cardiomyopathy: association with a novel POLG mutation? Neuropsychiatr Dis Treat. 2011;7:293-296. doi:10.2147/NDT.S20153 PubMed
49. Young TM, Blakely EL, Swalwell H, et al. Mitochondrial transfer RNA(Phe) mutation associated with a progressive neurodegenerative disorder characterized by psychiatric disturbance, dementia, and akinesia-rigidity. Arch Neurol. 2010;67(11):1399-1402. doi:10.101/archneurol.2010.283 PubMed
50. Friedman SD, Shaw DW, Ishak G, et al. The use of neuroimaging in the diagnosis of mitochondrial disease. Dev Disabil Res Rev. 2010;16(2):129-135. doi:10.102/dr.103 PubMed
51. Barragán-Campos HM, Vallée JN, Lô D, et al. Brain magnetic resonance imaging findings in patients with mitochondrial cytopathies. Arch Neurol. 2005;62(5):737-742. doi:10.101/archneur.62.5.737 PubMed (Pubitemid 40656088)
52. McFarland R, Turnbull DM. Batteries not included: diagnosis and management of mitochondrial disease. J Intern Med. 2009;265(2):210-228. doi:10.1/j.1365-2796.208.0206.x PubMed
53. Tarnopolsky MA, Raha S. Mitochondrial myopathies: diagnosis, exercise intolerance, and treatment options. Med Sci Sports Exerc. 2005;37(12):2086-2093. doi:10.1249/01.ms.017341.89478.06 PubMed (Pubitemid 41780735)
54. van Adel BA, Tarnopolsky MA. Metabolic myopathies: update 2009. J Clin Neuromuscul Dis. 2009;10(3):97-121. doi:10.1097/CND.0b013e3181903126 PubMed
55. Tarnopolsky MA. The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies. Adv Drug Deliv Rev. 2008;60(13-14):1561-1567. doi:10.1016/j.adr.208.05.01 PubMed
56. Rodriguez MC, MacDonald JR, Mahoney DJ, et al. Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders. Muscle Nerve. 2007;35(2):235-242. doi:10.102/mus.2068 PubMed
57. Glover EI, Martin J, Maher A, et al. A randomized trial of coenzyme Q10 in mitochondrial disorders. Muscle Nerve. 2010;42(5):739-748. doi:10.102/mus.21758 PubMed
58. Anglin RE, Rosebush PI, Mazurek MF. Treating psychiatric illness in patients with mitochondrial disorders [letter]. Psychosomatics. 2010;51(2):179. PubMed
59. Burkhardt C, Kelly JP, Lim YH, et al. Neuroleptic medications inhibit complex I of the electron transport chain. Ann Neurol. 1993;33(5):512-517. doi:10.102/ana.41030516 PubMed (Pubitemid 23143036)
60. Ponchaut S, Veitch K. Valproate and mitochondria. Biochem Pharmacol. 1993;46(2):199-204. doi:10.1016/06-2952(93)90404-K PubMed (Pubitemid 23218602)
61. Klopstock T, Jaksch M, Gasser T. Age and cause of death in mitochondrial diseases. Neurology. 1999;53(4):855-857. PubMed (Pubitemid 29448313)